NASDAQ:IMRX - Nasdaq - US45254E1073 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 78% to IMRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Date | Firm | Action | Rating |
---|---|---|---|
2025-01-13 | Needham | Reiterate | Buy -> Buy |
2025-01-08 | Chardan Capital | Maintains | Buy -> Buy |
2025-01-07 | Needham | Reiterate | Buy -> Buy |
2024-11-20 | Chardan Capital | Maintains | Buy -> Buy |
2024-11-14 | Needham | Reiterate | Buy -> Buy |
2024-09-13 | Needham | Reiterate | Buy -> Buy |
2024-08-07 | Chardan Capital | Maintains | Buy -> Buy |
2024-08-07 | Needham | Reiterate | Buy -> Buy |
2024-05-08 | Needham | Reiterate | Buy -> Buy |
2024-04-12 | Needham | Reiterate | Buy -> Buy |
2024-04-02 | Mizuho | Maintains | Buy -> Buy |
2024-03-15 | TD Cowen | Downgrade | Outperform -> Market Perform |
2024-03-15 | Chardan Capital | Maintains | Buy -> Buy |
2024-03-15 | Needham | Maintains | Buy -> Buy |
2024-03-15 | Jefferies | Downgrade | Buy -> Hold |
2024-03-14 | Guggenheim | Downgrade | Buy -> Neutral |
2024-03-11 | Needham | Reiterate | Buy -> Buy |
2024-03-05 | Oppenheimer | Reiterate | Outperform -> Outperform |
2024-03-04 | Needham | Reiterate | Buy -> Buy |
2024-02-01 | Needham | Reiterate | Buy -> Buy |
2023-12-01 | Needham | Initiate | Buy |
2023-08-08 | Oppenheimer | Reiterate | Outperform -> Outperform |
2023-08-07 | Chardan Capital | Reiterate | Buy -> Buy |
2023-08-04 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
2023-04-19 | Chardan Capital | Maintains | Buy |
2023-04-19 | Mizuho | Upgrade | Neutral -> Buy |
2023-04-19 | Morgan Stanley | Upgrade | Underweight -> Equal-Weight |
2023-04-18 | Chardan Capital | Maintains | Buy |
2023-03-30 | Mizuho | Initiate | Neutral |
2023-03-07 | Chardan Capital | Reiterate | Buy |